News | SPECT Imaging | June 21, 2018

New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging

New guideline published by the American Society of Nuclear Cardiology provides an update to the 2010 ASNC SPECT guidelines

New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging

June 21, 2018 — The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon emission computed tomography (SPECT), with a focus on advances in myocardial perfusion imaging (MPI). The 2018 guideline is designed to provide MPI guidelines for conventional and novel SPECT for all nuclear cardiology practitioners.

The new guideline — “ASNC Imaging Guidelines: Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging—Instrumentation, Acquisition, Processing, and Interpretation” — features updates on novel hardware, collimators and cadmium zinc telluride (CZT) scanners. The update also features brand-new sections on:

  • Reduced count density reconstruction techniques;
  • SPECT myocardial blood flow quantification;
  • Stress-first/stress-only imaging; and
  • Patient-centered myocardial perfusion imaging.

“Recent breakthroughs in SPECT technology enable, for the first time, exceedingly low radiation dose imaging, myocardial blood flow quantitation and personalized imaging protocols,” stated Sharmila Dorbala, M.D., MPH, FASNC, lead author of the guideline. “These advances have transformed SPECT myocardial perfusion imaging, as we know it. We hope that by standardizing the contemporary practice of SPECT MPI, these guidelines will ultimately benefit patients with heart disease.”

The guideline earned the endorsement of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and is published in the Journal of Nuclear Cardiology. The new SPECT guideline can be viewed here.

“It highlights very important advances in contemporary SPECT MPI while also providing guidance on best practices for performing high-quality, patient-centered imaging for optimal results that will have a meaningful impact on patient management and outcomes,” said Panithaya Chareonthaitawee, M.D., co-author and president of the SNMMI Cardiovascular Council. “The document will be an extremely valuable resource for members of ASNC, SNMMI and the nuclear cardiology community.”

For more information: www.asnc.org

Reference

Dorbala S., Ananthasubramaniam K., Armstrong I.S., et al. "Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation." Journal of Nuclear Cardiology. https://doi.org/10.1007/s12350-018-1283-y

Related Content

Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
Overlay Init